Form 4: Accolade Inc. Director Michael W. Hilton Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Michael W. Hilton reports acquisition of 12,489 Restricted Stock Units (RSUs) in Accolade, Inc. on March 3, 2025, according to a Form 4 filing.

Summary

  • On March 3, 2025, Michael W. Hilton, a director of Accolade, Inc., acquired 12,489 Restricted Stock Units (RSUs).
  • Each RSU represents a contingent right to receive one share of Accolade's Common Stock.
  • The RSUs vest at a rate of 25% each quarter, starting from March 1, 2025, provided continuous service is maintained.
  • The RSUs will be fully vested on the one-year anniversary of the Vesting Commencement Date.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard reporting of stock unit acquisition. It doesn't inherently indicate positive or negative performance.

Future Outlook

The RSUs vest over time contingent on continued service, aligning the director's interests with the company's long-term performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

  • The acquisition of RSUs by a director can align their interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

DateDescription
03/01/2025Vesting Commencement Date for the Restricted Stock Units
03/03/2025Date of transaction: Acquisition of Restricted Stock Units
03/05/2025Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.